NEWS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
“Unnatural Selection”
BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, "Unnatural Selection" in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan Schaeffer. Read More
Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics. Company’s First Major Collaboration Validates Potential of Biochemical Protein Synthesis Technology Platform.
San Francisco, CA Jan. 7, 2011 - Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that the company has entered into a multi-year collaboration with Pfizer for...
Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer Appointment Reflects Biopharmaceutical Company’s Commitment to the Development of Novel and Biosuperior Protein Therapeutics
San Francisco, CA Dec. 8, 2010 - Sutro Biopharma, a biopharmaceutical company developing both novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that it has appointed Trevor Hallam, Ph.D., as chief scientific officer...
A Robust, Rapid and Scalable Cell Free Expression System for the Production and Engineering of Fab Antibodies
Garces, Eudean et. al., A robust, rapid and scalable cell free expression system for the production and engineering of Fab antibodies. Presented at the IBC 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Convention, San Diego, CA....
Sutro Biopharma Secures $36.5 Million in Series C Financing
South San Francisco, CA Nov. 17, 2010 - Sutro Biopharma today announced that the company has secured $36.5 million in Series C financing. This financing will support the company's ongoing development of novel biotherapeutics with superior pharmaceutical properties and...
Translation Fidelity Rate Determination in a Cell-Free Protein Synthesis System using LC-MS
Heibeck, Tyler H., et. al., Translation Fidelity Rate Determination in a Cell-Free Protein Synthesis System using LC-MS. 58th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics,Salt Lake City, UT. Read More
Towards scalable cell-free synthesis of non-native amino acid containing proteins
Rozzelle, James E., et.al., Towards scalable cell-free synthesis of non-native amino acid containing proteins. Presented at American Chemical Society Spring Meeting, San Francisco, CA. Read More
Sutro Biopharma and Promising Protein Synthesis Technology
National Science Foundation (NSF) newsletter featuring Sutro Biopharma and Promising Protein Synthesis Technology. Read More
Sutro Biopharma Announces Additions to Board of Directors and Senior Management Team
South San Francisco, CA (August 20, 2009) Sutro Biopharma, Inc., the leader in open cell-free synthesis (OCFS) for the discovery and production of proteins, today announced several key appointments to the company’s management. Daniel H. Petree of P2 Partners, LLC has...
Sutro Biopharma Adds to Extensive IP Portfolio with Two Newly Issued Patents and Two Patent Grant Notices — Covers the Only Cell-Free Synthesis Platform Applicable to Protein Discovery Through Production —
South San Francisco, CA (June 9, 2009) Sutro Biopharma, Inc., the leader in open cell-free synthesis (OCFS) for the discovery and production of proteins, announced today that two additional patents, as well as two patent grant notices, have issued pertaining to...